Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.54
0.040.73%
Last update: Oct 2, 4:00 PM
$5.54
0.040.73%
Aligos Therapeutics Inc (ALGS) Stock Price, Quote, News & History
ALGSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Aligos Therapeutics (NASDAQ:ALGS) through any online brokerage.
Other companies in Aligos Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Aligos Therapeutics has a consensus price target of $43.00.
The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $5.54 last updated October 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Aligos Therapeutics.
Aligos Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Aligos Therapeutics.
Aligos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
